Speaker illustration

Doctor Stefan Mulverstedt

Bispebjerg University Hospital, Copenhagen (Denmark)

Treatment of Hypercholesterolaemia with PCSK9 Inhibitors in Denmark. Assessment of real-life data; Extent and Efficacy after the first years of clinical use

Event: ESC CONGRESS 2019

Topic: Lipid-Lowering Agents

Session: PCSK9 inhibitors: from cells to patients

Thumbnail

Treatment of hypercholesterolaemia with PCSK-9 Inhibitors in Denmark. Assessment of real-life data; safety an extent of adverse effects after the first years of clinical use.

Event: ESC CONGRESS 2019

Topic: Lipid-Lowering Agents

Session: Preclinical pharmacotherapy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk